Ecrins Therapeutics SAS logo

Ecrins Therapeutics SAS

Ecrins Therapeutics SAS. researches, discovers, and develops anti cancer drugs. It develops ET-D5, a small molecule drug candidate for various oncology indications; and tubulin polymerization kits and native tubulin for applications, such as in vitro microtubule assembly, monitoring microtubule assembly in microscopy, and monitoring in vitro tubulin polymerization in the presence of small molecules or proteins that can impact microtubule assembly.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://ecrins-therapeutics.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Biopolis5 avenue du Grand Sablon,38700
La Tronche
France
Email
Contact Number
+33 4 56 52 06 24

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/ecrins-therapeutics-sas” connections=”true” suffix=””]